| NCT ID | NCT03765333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Grupo Espanol de Tumores Neuroendocrinos |
| Condition | Thyroid Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2019-05-28 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2019-05-28 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with diagnosis of primary thyroid cancer.
Eligibility Criteria
Inclusion Criteria: * Patients older than 18 years with diagnosis of differentiated, medullary or anaplastic thyroid cancer confirmed by histopathology. * Patients who agree to participate and are able to understand the information sheet and sign the informed consent Exclusion Criteria: * Patients under 18 years of age. * Patients with other types of thyroid cancer or whose histopathological diagnosis has not been confirmed. * Patients who do not have the relevant basic information to be included in the study, according to the criteria of the principal investigator.
Contact & Investigator
Jorge Hernando Cubero, M.D.
STUDY DIRECTOR
Hospital Universitari Vall d'Hebron, Barcelona
Frequently Asked Questions
Who can join the NCT03765333 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thyroid Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03765333 currently recruiting?
Yes, NCT03765333 is actively recruiting participants. Contact the research team at getne@mfar.net for enrollment information.
Where is the NCT03765333 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT03765333 clinical trial?
NCT03765333 is sponsored by Grupo Espanol de Tumores Neuroendocrinos. The principal investigator is Jorge Hernando Cubero, M.D. at Hospital Universitari Vall d'Hebron, Barcelona. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.